The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NMD Pharma’s oral lead development programme, NMD670, designed to treat Charcot-Marie-Tooth disease (CMT).

This course explores various behavioural modelling techniques used in treasury management, including prepayment modelling and NMD modelling. Participants will examine the crucial role behavioural ...

Our study highlights the decline of UPF1, a key component of nonsense-mediated mRNA decay (NMD), during cellular senescence and its impact on NMD efficiency, leading to the accumulation of ...